MUC-1 vaccine associated with notable overall survival rates in breast cancerJune 27, 2024Breast CancerLung Cancer
One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Obesity and Cancer: Untangling a Complex WebMay 28, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMixed Topics
Urine Tests Could Be ‘Enormous Step’ in Diagnosing CancerMay 22, 2024Breast CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerMelanomaLymphoma & Plasma Cell DisordersOncology
New mRNA Vaccines in Development for Cancer and InfectionsMay 10, 2024Breast CancerHead & Neck/Thyroid CancersGenitourinary CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Can a Risk Score Predict Kidney Injury After Cisplatin?May 10, 2024Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaMixed Topics
Do Patients Benefit from Cancer Trial Participation?May 8, 2024MelanomaLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMelanoma
